Regulus Therapeutics Announces Restructuring of Sanofi and Oxford Loan Agreements
LA JOLLA, Calif., Aug. 31, 2020 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced that pursuant to an amendment of its term loan agreement with Oxford…
Comments Off on Regulus Therapeutics Announces Restructuring of Sanofi and Oxford Loan Agreements